ENTRY       D06285                      Drug
NAME        Vatalanib (USAN/INN)
FORMULA     C20H15ClN4
EXACT_MASS  346.0985
MOL_WEIGHT  346.8129
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
EFFICACY    Antineoplastic, Angiogenesis inhibitor, Receptor tyrosine kinase inhibitor
TARGET      PDGFRB [HSA:5159] [KO:K05089]
            VEGFR1 (FLT1) [HSA:2321] [KO:K05096]
            VEGFR2 (KDR) [HSA:3791] [KO:K05098]
            VEGFR3 (FLT4) [HSA:2324] [KO:K05097]
            KIT (CD117) [HSA:3815] [KO:K05091]
  PATHWAY   hsa04010(2321+2324+3791+3815+5159)  MAPK signaling pathway
            hsa04151(2321+2324+3791+3815+5159)  PI3K-Akt signaling pathway
            hsa04370(3791)  VEGF signaling pathway
            hsa05200(2324+3815+5159)  Pathways in cancer
INTERACTION  
STR_MAP     map07045  Antineoplastics - protein kinase inhibitors
BRITE       Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                D06285  Vatalanib
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               PDGFR family
                PDGFRB
                 D06285  Vatalanib (USAN/INN)
                KIT (CD117)
                 D06285  Vatalanib (USAN/INN)
               VEGFR family
                VEGFR1 (FLT1)
                 D06285  Vatalanib (USAN/INN)
                VEGFR2 (KDR)
                 D06285  Vatalanib (USAN/INN)
                VEGFR3 (FLT4)
                 D06285  Vatalanib (USAN/INN)
DBLINKS     CAS: 212141-54-3
            PubChem: 47207942
            ChEBI: 90620
            LigandBox: D06285
ATOM        25
            1   C8x C    20.3121  -19.0002
            2   C8x C    20.3121  -20.4008
            3   C8x C    21.5280  -21.1011
            4   C8x C    21.5280  -18.3000
            5   C8y C    22.7367  -19.0002
            6   C8y C    22.7308  -20.4008
            7   C8y C    23.9407  -21.1061
            8   N5x N    25.1566  -20.4111
            9   N5x N    25.1625  -19.0106
            10  C8y C    23.9526  -18.3053
            11  N1b N    23.9585  -16.9047
            12  C8y C    25.1746  -16.2095
            13  C8x C    26.4164  -16.9331
            14  C8x C    27.6316  -16.2380
            15  C8y C    27.6373  -14.8380
            16  C8x C    26.3954  -14.1144
            17  C8x C    25.1802  -14.8095
            18  X   Cl   28.8612  -14.1378
            19  C1b C    23.9346  -22.5400
            20  C8y C    25.1481  -23.2475
            21  C8x C    25.1421  -24.6399
            22  C8x C    26.3515  -25.3452
            23  N5x N    27.5669  -24.6504
            24  C8x C    27.5729  -23.2580
            25  C8x C    26.3635  -22.5527
BOND        28
            1     1   2 2
            2     2   3 1
            3     3   6 2
            4     5   4 2
            5     5   6 1
            6     6   7 1
            7     7   8 2
            8     8   9 1
            9     9  10 2
            10   10   5 1
            11    4   1 1
            12   10  11 1
            13   11  12 1
            14   12  13 2
            15   13  14 1
            16   14  15 2
            17   15  16 1
            18   16  17 2
            19   12  17 1
            20   15  18 1
            21    7  19 1
            22   19  20 1
            23   20  21 2
            24   21  22 1
            25   22  23 2
            26   23  24 1
            27   24  25 2
            28   20  25 1
///
